Results 11 to 20 of about 457,015 (304)

Chronic Hepatitis D Virus Infection and Its Treatment: A Narrative Review [PDF]

open access: yesMicroorganisms
More than 12 million individuals worldwide are chronically infected with the hepatitis D virus (HDV). HDV infection is the most severe form of viral hepatitis since it requires hepatitis B virus co-infection and accelerates progression to cirrhosis and ...
Poonam Mathur   +2 more
doaj   +2 more sources

Hepatitis D Virus Infection Revisited [PDF]

open access: yesGastroenterology, 2019
No abstract ...
Verrier, Eloi   +2 more
openaire   +3 more sources

Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis

open access: yesThe Lancet Global Health, 2017
Background: Hepatitis D virus (also known as hepatitis delta virus) can establish a persistent infection in people with chronic hepatitis B, leading to accelerated progression of liver disease. In sub-Saharan Africa, where HBsAg prevalence is higher than
Alexander J Stockdale, MRes   +8 more
doaj   +1 more source

Hepatitis D Virus Replication [PDF]

open access: yesCold Spring Harbor Perspectives in Medicine, 2015
This work reviews specific related aspects of hepatitis delta virus (HDV) reproduction, including virion structure, the RNA genome, the mode of genome replication, the delta antigens, and the assembly of HDV using the envelope proteins of its helper virus, hepatitis B virus (HBV).
openaire   +2 more sources

Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-Naïve chronic HBV patients [PDF]

open access: yes, 2013
Background: Immunomodulators and Nucleotide analogues have been used globally for the dealing of chronic hepatitis B virus (HBV) infection. However, the development of drug resistance is a major limitation to their long-term effectiveness.
Abedi, F.   +33 more
core   +1 more source

Bulevirtide plus Tenofovir Disoproxil Fumarate Improves Liver Function in HDV/HBV Related Cirrhosis after Virological Response: A Case Report

open access: yesGastrointestinal Disorders, 2022
Hepatitis D virus (HDV) globally affects nearly 5% of people with chronic hepatitis B virus (HBV) infection. Bulevirtide (BLV) is an HDV/HBV entry inhibitor recently approved for adult patients with chronic hepatitis delta (CHD).
Nikolaos Papadopoulos   +3 more
doaj   +1 more source

Hepatitis D virus: an update [PDF]

open access: yesLiver International, 2010
AbstractHepatitis D virus (HDV) infection involves a distinct subgroup of individuals simultaneously infected with the hepatitis B virus (HBV) and characterized by an often severe chronic liver disease. HDV is a defective RNA agent needing the presence of HBV for its life cycle.
Pascarella Rochat, Stéphanie   +1 more
openaire   +3 more sources

BIBLIOMETRIC ANALYSIS OF PUBLICATIONS ON HEPATITIS D VIRUS PUBLISHED IN 1984–2022

open access: yesCentral Asian Journal of Medical Hypotheses and Ethics, 2023
Background: Hepatitis D virus research has advanced in recent decades. In this study, we aim to quantitatively analyze the scientific data in the field of "hepatitis D virus" by using bibliometric analysis. Methods: Research documents published in the
Mehmet Çelik   +4 more
doaj   +1 more source

Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran [PDF]

open access: yes, 2014
Background: Hepatitis B infection, caused by hepatitis B Virus (HBV), is one of the major global public health problems. Hepatitis B Virus genotypes appear to show varying geographic distribution with possible pathogenic and therapeutic differences ...
Bahramali G   +17 more
core   +1 more source

Clinical, epidemiological and virological features of acute hepatitis B in Italy [PDF]

open access: yes, 2015
Purpose To evaluate the association of hepatitis B virus (HBV) genotypes, basal core promoter (BCP)/precore (PC) and S gene mutations with the clinical-epidemiological characteristics of acute hepatitis B (AHB) in Italy.
Alessandro Remo Zanetti   +10 more
core   +1 more source

Home - About - Disclaimer - Privacy